108 related articles for article (PubMed ID: 239539)
1. Drug metabolism in isolated rat liver cells.
Grudin R; Moldèus P; Vadi H; Orrenius S
Adv Exp Med Biol; 1975; 58(00):251-69. PubMed ID: 239539
[No Abstract] [Full Text] [Related]
2. Proceedings: Isolated liver cells: a valuable tool for the study of drug metabolism.
Moldéus P; Grundlin R; Vadi H; Orrenius S
Z Klin Chem Klin Biochem; 1975 Aug; 13(8):375. PubMed ID: 3043
[No Abstract] [Full Text] [Related]
3. A study of drug metabolism linked to cytochrome P-450 in isolated rat-liver cells.
Moldéus P; Grundin R; Vadi H; Orrenius S
Eur J Biochem; 1974 Jul; 46(2):351-60. PubMed ID: 4152752
[No Abstract] [Full Text] [Related]
4. The possible role of cytochrome P-450 in the liver "first pass elimination" of a beta-receptor blocking drug.
Grundin R; Moldéus P; Orrenius S; Borg KO; Skånberg I; von Bahr C
Acta Pharmacol Toxicol (Copenh); 1974 Sep; 35(3):242-60. PubMed ID: 4479306
[No Abstract] [Full Text] [Related]
5. [Role of cytochrome P-450 in mixed function oxidation and metabolism of anesthetics].
Shigematsu A; Takahashi S; Furukawa T
Masui; 1974 Feb; 23(2):89-98. PubMed ID: 4603810
[No Abstract] [Full Text] [Related]
6. Characteristics of the activation of cyclophosphamide to a mutagen by rat liver.
Hales BF; Jain R
Biochem Pharmacol; 1980 Feb; 29(2):256-9. PubMed ID: 6767482
[No Abstract] [Full Text] [Related]
7. Liver microsomal metabolism of N-methylcarbazole: a probe for induction, inhibition, and species differences.
Koop DR; Hollenberg PF
Mol Pharmacol; 1980 Jan; 17(1):118-27. PubMed ID: 7383014
[No Abstract] [Full Text] [Related]
8. Cytochrome P-450 and drug metabolism in Trypanosoma cruzi: effects of phenobarbital.
Agosin M; Naquira C; Paulin J; Capdevila J
Science; 1976 Oct; 194(4261):195-7. PubMed ID: 785602
[TBL] [Abstract][Full Text] [Related]
9. Metabolic activation of halothane and its covalent binding to liver endoplasmic proteins in vitro.
Uehleke H; Hellmer KH; Tabarelli-Poplawski S
Naunyn Schmiedebergs Arch Pharmacol; 1973; 279(1):39-52. PubMed ID: 4147966
[No Abstract] [Full Text] [Related]
10. The binding of metyrapone to cytochrome P-450 and its inhibitory action on microsomal hepatic mixed function oxidation reactions.
Hildebrandt AG
Biochem Soc Symp; 1972; 34():79-102. PubMed ID: 4570969
[No Abstract] [Full Text] [Related]
11. The metabolism of 1-phenyl-2-(N-methyl-N-furfurylamino)propane (furfenorex) in the rat in vivo and in vitro.
Inoue T; Yasuda T; Suzuki S; Kishi T; Niwaguchi T
Xenobiotica; 1986 Feb; 16(2):109-21. PubMed ID: 3962333
[TBL] [Abstract][Full Text] [Related]
12. Studies on the metabolism of ethynylestradiol in vitro and in vivo: the significance of 2-hydroxylation and the formation of polar products.
Bolt HM; Kappus H; Remmer H
Xenobiotica; 1973 Dec; 3(12):773-85. PubMed ID: 4150680
[No Abstract] [Full Text] [Related]
13. The effect of chlorpromazine, metyrapone, imipramine and SKF 525-A on the hepatic first pass elimination of propranolol in the pithed rat.
Barber HE; Kitteringham NR; Petrie JC
Br J Pharmacol; 1982 Dec; 77(4):667-77. PubMed ID: 7150874
[TBL] [Abstract][Full Text] [Related]
14. Mixed function oxidation and intermediary metabolism: metabolic interdependencies in the liver.
Thurman RG; Marazzo DP
Adv Exp Med Biol; 1975; 58(00):355-67. PubMed ID: 239540
[TBL] [Abstract][Full Text] [Related]
15. Spectral evidence for a liver mitochondrial cytochrome P450 involved in bile acid metabolism.
Okuda K; Ruf HH; Ullrich V
Hoppe Seylers Z Physiol Chem; 1977 Jun; 358(6):689-94. PubMed ID: 195887
[TBL] [Abstract][Full Text] [Related]
16. Studies on the rate of reduction of hepatic microsomal cytochrome P-450 by reduced nicotinamide adenine dinucleotide phosphate: effect of drug substrates.
Gigon PL; Gram TE; Gillette JR
Mol Pharmacol; 1969 Mar; 5(2):109-22. PubMed ID: 4389181
[No Abstract] [Full Text] [Related]
17. Oxidative and conjugative metabolism of p-nitroanisole and p-nitrophenol in isolated rat liver cells.
Moldéus P; Vadi H; Berggren M
Acta Pharmacol Toxicol (Copenh); 1976 Jul; 39(1):17-32. PubMed ID: 988967
[No Abstract] [Full Text] [Related]
18. Kinetic experiments on the synergistic effect of NADH on microsomal drug oxidation.
Netter KJ; Illing HP
Xenobiotica; 1974 Sep; 4(9):549-61. PubMed ID: 4372813
[No Abstract] [Full Text] [Related]
19. Biotransformation of lovastatin. II. In vitro metabolism by rat and mouse liver microsomes and involvement of cytochrome P-450 in dehydrogenation of lovastatin.
Vyas KP; Kari PH; Prakash SR; Duggan DE
Drug Metab Dispos; 1990; 18(2):218-22. PubMed ID: 1971576
[TBL] [Abstract][Full Text] [Related]
20. In vitro hepatic and extra-hepatic reduction of (minus)-nicotine-1'-N-oxide in rats.
Dajani RM; Gorrod JW; Beckett AH
Biochem Pharmacol; 1975 Jan; 24(1):109-17. PubMed ID: 235926
[No Abstract] [Full Text] [Related]
[Next] [New Search]
